Back
Monte Rosa Therapeutics Vs. Preformed Line Products Industry Stock Comparison
Buy
64
GLUE
Monte Rosa Therapeutics
Last Price:
$6.29
Seasonality Move:
-24.75%
Buy
62
PLPC
Preformed Line Products
Last Price:
$144.96
Seasonality Move:
7.37%
Buy
64
Monte Rosa Therapeutics (GLUE)
is a Buy
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
-
The current Monte Rosa Therapeutics [GLUE] share price is $6.27. The Score for GLUE is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
GLUE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Preformed Line Products (PLPC)
is a Buy
Is Preformed Line Products a Buy, Sell or Hold?
-
The current Preformed Line Products [PLPC] share price is $145.03. The Score for PLPC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
PLPC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $6.27The current trend is relatively stagnant and GLUE is experiencing slight selling pressure.
PLPC Stock Price Chart
What is Preformed Line Products's stock price today?
-
The Preformed Line Products share price today is $145.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLPC is experiencing slight buying pressure.
GLUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 51.1 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.85 - 6.69) | Sell |
Bollinger Bands (100): | (5.7 - 8.62) | Sell |
PLPC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.44 | Sell |
Relative Strength Index (14 RSI): | 66.47 | Buy |
Chaikin Money Flow: | 15747 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (125.53 - 143.37) | Buy |
Bollinger Bands (100): | (124.98 - 140.1) | Buy |
GLUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.23 | Buy |
20-day SMA: | 6.19 | Buy |
50-day SMA: | 6.24 | Buy |
200-day SMA: | 5.96 | Buy |
8-day EMA: | 6.22 | Buy |
20-day EMA: | 6.2 | Buy |
50-day EMA: | 6.42 | Sell |
200-day EMA: | 6.33 | Sell |
PLPC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.58 | Buy |
20-day SMA: | 131.95 | Buy |
50-day SMA: | 133.54 | Buy |
200-day SMA: | 128.03 | Buy |
8-day EMA: | 129.06 | Buy |
20-day EMA: | 130.88 | Buy |
50-day EMA: | 132.75 | Buy |
200-day EMA: | 130.26 | Buy |
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.24 per share.
Preformed Line Products Earnings Growth & PLPC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monte Rosa Therapeutics Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Preformed Line Products Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |